|
|
 |
|
Viewing report
|
|
|
|
Analgesics in Russia
Euromonitor International, Dec 2007, Pages: 45
Our Analgesics in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.
Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics
Data coverage: market sizes (historic and forecasts), company shares, brand shares
Why buy this report?
- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop
EXECUTIVE SUMMARY
Health Standards Remain Low But Improve
Health levels remain low in Russia, with heavy smoking, poor diets and alcohol and drug abuse resulting in increasing rates of disease. This trend was further exacerbated by an ageing population. The deteriorating health of the Russian population, coupled with rising disposable income levels, resulted in more consumers purchasing a wider variety of OTC healthcare more frequently. Simultaneously, players launched more products to take
advantage of sales dynamism and chained chemists/pharmacies continued to expand across the country. These factors therefore supported strong overall growth in OTC healthcare in 2006 over the previous year.
NRT Smoking Cessation Aids Dynamic But From Low Base
NRT smoking cessation aids saw the strongest current value growth in 2006 over the previous year. However, this was chiefly due to a low base, with these products first gaining a significant presence in 2005. These products are proving increasingly popular but sales remain largely limited to the major cities. There is a huge smoking population in Russia but most are unaware of or uninterested in the potential risks of smoking. Strong consumer education campaigns will be required to support stronger growth.
Fragmented Sales Led by Multinationals
OTC healthcare is extremely fragmented, with a large range of players. The leaders are multinationals, including Novartis, Berlin Chemie, Aventis, GlaxoSmithKline and Krka. These players benefit from high quality products and strong funds for investment in new product development and marketing. With rising disposable income levels, many consumers traded up from domestic generics and unbranded products to products from multinationals, which are often viewed as offering higher quality.
Consumers Prefer Specialised Distribution Outlets
Chemists/pharmacies continued to be the most significant distribution channel for OTC healthcare during the review period. Most consumers prefer this channel, believing it to offer expert advice. In addition, its lead was supported by the expansion of chains across Russia. Direct sales is also significant, however, particularly in vitamins and dietary supplements. Grocery outlets is meanwhile fairly undeveloped, with only larger urban outlets offering a limited range of vitamins and dietary supplements.
Faster Growth in Forecast Period
OTC healthcare is expected to see even stronger constant value growth during the forecast period. Growth will be partly underpinned by increasing consumer demand, driven by rising disposable income levels, a growing interest in health and widening awareness of OTC healthcare. In addition, growth will be driven by players, with more players expected to enter this dynamic area during the forecast period, often through the acquisition of or investment in local producers. Players will launch numerous value-added products, with a growing focus on quality as they attempt to meet changing consumer demands. Finally, the spread of chained chemists/pharmacies across the regions will make a wider range of OTC healthcare available to more consumers during the forecast period.
Customers who bought this item also bought
OTC Healthcare - Macedonia
Analgesics in Portugal
Analgesics in Slovakia
Analgesics in Germany
Analgesics in Chile
OTC Healthcare - Ecuador
Analgesics in Spain
Analgesics in Hungary
Analgesics in Romania
Analgesics in Finland
Analgesics in Indonesia
Analgesics in Denmark
|
|
|
|
